Mary Kerr
Chief Executive Officer chez NeRRe Therapeutics Ltd.
Profil
Mary Kerr is the founder of KaNDy Therapeutics Ltd.
which was founded in 2017.
She is currently the Chief Executive Officer & Director at NeRRe Therapeutics Ltd.
since 2015 and a Director at NeRRe Therapeutics Holdings Ltd.
since 2017.
Dr. Kerr's former positions include being an Independent Non-Executive Director at Galapagos NV from 2016 to 2023, a Senior Vice President at Global Franchise Group LLC, and a Member at ViiV Healthcare Ltd.
Dr. Kerr holds a doctorate from the University of Bradford and an MBA from Kingston University.
Postes actifs de Mary Kerr
Sociétés | Poste | Début |
---|---|---|
NeRRe Therapeutics Ltd.
NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Chief Executive Officer | 01/09/2015 |
NeRRe Therapeutics Holdings Ltd.
NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services NeRRe Therapeutics Holdings Ltd. is a British biotechnology company founded in 2017. The private company is based in Stevenage, UK. The company is engaged in research and development of biotechnology. | Director/Board Member | 08/09/2017 |
Anciens postes connus de Mary Kerr
Sociétés | Poste | Fin |
---|---|---|
GALAPAGOS NV | Director/Board Member | 18/09/2023 |
KaNDy Therapeutics Ltd.
KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Founder | 01/09/2020 |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Corporate Officer/Principal | - |
Global Franchise Group LLC
Global Franchise Group LLC Food RetailRetail Trade Global Franchise Group LLC operates as a strategic brand management company with a focus on franchising. It specializes in franchising restaurant industries. The company was founded in 2010 and is headquartered in Atlanta, GA. | Corporate Officer/Principal | - |
Formation de Mary Kerr
University of Bradford | Doctorate Degree |
Kingston University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
GALAPAGOS NV | Health Technology |
Entreprise privées | 5 |
---|---|
Global Franchise Group LLC
Global Franchise Group LLC Food RetailRetail Trade Global Franchise Group LLC operates as a strategic brand management company with a focus on franchising. It specializes in franchising restaurant industries. The company was founded in 2010 and is headquartered in Atlanta, GA. | Retail Trade |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
NeRRe Therapeutics Ltd.
NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Distribution Services |
KaNDy Therapeutics Ltd.
KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
NeRRe Therapeutics Holdings Ltd.
NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services NeRRe Therapeutics Holdings Ltd. is a British biotechnology company founded in 2017. The private company is based in Stevenage, UK. The company is engaged in research and development of biotechnology. | Commercial Services |